Are stem cells drugs? The regulation of stem cell research and development

Circulation

Volumn 114, Issue 18, 2006, Pages 1992-2000

  Rosen, Michael R ^a  

^a Columbia University ^*  (United States)

Author keywords

Cardiovascular diseases; Cells; Heart failure; Myocardial infarction; Trials

Indexed keywords

DOXORUBICIN;

AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; COMBINED IMMUNODEFICIENCY; DEATH; EUROPE; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; GRAFT REJECTION; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HUMAN; LEUKEMIA; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; MESENCHYMAL STEM CELL; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOCIAL BEHAVIOR; ST SEGMENT ELEVATION; STEM CELL; STEM CELL TRANSPLANTATION; STENT;

BIOMEDICAL RESEARCH; BONE MARROW TRANSPLANTATION; EMBRYO RESEARCH; HEART DISEASES; HISTORY, 20TH CENTURY; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); STEM CELL TRANSPLANTATION; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33750497839     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.641670     Document Type: Review

References (61)

1. Stein J, Harnick S, Bock J. Fiddler on the Roof. New York, NY: Crown Publishers; 1964.
2. Tanneeru M. Legislation can't keep pace with technology: industry observers say outdated regulations a drag on innovation. CNN. October 18, 2005.
3. Bohme G. Cultural resources for coping with technological progress. Jephcott E, trans. In: List E, Fiala E, eds. Grundlagen der Kulturwissenschaften. Tubingen: Interdisziplinare Kulturstudien; 2004.
4. Warnock M. The regulation of technology. Camb Q Healthc Ethics. 1998;7:173-175.
5. Berg P. Asilomar and recombinant DNA. 2004. Available at: http://nobelprize.org/nobel prizes/chemistry/articles/berg/index.html. Accessed October 9, 2006.
6. Aries P. Western Attitudes Toward Death. Ranum PM, trans. Baltimore, Md: Johns Hopkins University Press; 1974.
7. Smith GP. Setting limits: medical technology and the law. Syd Law Rev. 2001;23:283-296.
8. Orlic D, Hill JM, Arai A. Stem cells for myocardial regeneration. Circ Res. 2005;91:1092-1102.
9. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, Rossi MI, Carvalho AC, Dutra HS, Dohmann HJ, Silva GV, Belem L, Vivacqua R, Rangel FO, Esporcatte R, Geng YJ, Vaughn WK, Assad JA, Mesquita ET, Willerson JT. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 2003;107:2294-2302.
10. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, Grunwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, Zeiher AM. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation. 2002;106:3009-3017.
11. Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, Abolmaali ND, Vogl TJ, Hofmann WK, Martin H, Dimmeler S, Zeiher AM. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial. J Am Coll Cardiol. 2004;44:1690-1699.
12. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H, Schumichen C, Nienaber CA, Freund M, Steinhoff G. Autologous bonemarrow stem-cell transplantation for myocardial regeneration. Lancet. 2003;361:45-46.
13. Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, Kogler G, Wernet P. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 2002;106:1913-1918.
14. Mooney C. The Republican War on Science. New York, NY: Basic Books; 2005.
15. Wade N. Tracking the uncertain science of growing heart cells. New York Times. March 14, 2005.
16. Committee on Guidelines for Human Embryonic Stem Cell Research, National Research Council. Guidelines for Human Embryonic Stem Cell Research. Washington, DC: National Academies Press; 2005.
17. Cook E. Amid South Korea scandal: cloning race is on. The Boston Globe. December 24, 2005.
18. Normile D, Vogel G. Stem cells: Korean University will investigate cloning paper. Science. 2005;310:1748-1749.
19. Thomas ED, Lochte HL Jr, Lu WC, Ferrebee JW. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med. 1957;257:491-496.
20. Thomas ED. The Nobel Lectures in Immunology: the Nobel Prize for Physiology or Medicine, 1990: bone marrow transplantation: past, present and future. Scand J Immunol. 1994;39:339-345.
21. Scott CT. Stem Cell Now. New York, NY: Pi Press; 2006:96.
22. Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, Fichtner S, Hecker H, Schaefer A, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (Bone Marrow Transfer to Enhance ST-Elevation Infarct Regeneration) trial. Circulation. 2006;113:1287-1294.
23. Welt FG, Losordo DW. Cell therapy for acute myocardial infarction: curb your enthusiasm? Circulation. 2006;113:1272-1274.
24. Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood. 2003;101:2999-3001.
25. Saito T, Kuang JQ, Bittira B, Al-Khaldi A, Chiu RC. Xenotransplant cardiac chimera: immune tolerance of adult stem cells. Ann Thorac Surg. 2002;74:19-24.
26. Devine SM, Bartholomew AM, Mahmud N, Nelson M, Patil S, Hardy W, Sturgeon C, Hewett T, Chung T, Stock W, Sher D, Weissman S, Ferrer K, Mosca J, Deans R, Moseley A, Hoffman R. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol. 2001;29:244-255.
27. Nagaya N, Fujii T, Iwase T, Ohgushi H, Itoh T, Uematsu M, Yamagishi M, Mori H, Kangawa K, Kitamura S. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol. 2004;287:H2670-H2676.
28. Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, Miller L, Guetta E, Zipori D, Kedes LH, Kloner RA, Leor J. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation. 2003;108:863-868.
29. Zimmett JM, Hare JM. Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy. Basic Res Cardiol. 2005;100:471-481.
30. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringdén O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol. 2003;57:11-20.
31. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation. 2003;75:389-397.
32. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, Hardy W, Devine S, Ucker D, Deans R, Moseley A, Hoffman R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol. 2002;30:42-48.
33. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105:1815-1822.
34. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002;99:3838-3843.
35. Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, Dazzi F. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood. 2003;101:3722-3729.
36. Le Blanc K, Rasmusson I, Gotherstrom C, Seidel C, Sundberg B, Sundin M, Rosendahl K, Tammik C, Ringden O. Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scand J Immunol. 2004;60:307-315.
37. Menasche P. Cell transplantation in myocardium. Ann Thorac Surg. 2005;75:S20-S28.
38. Amado LC, Saliaris AP, Schuleri KH, St John M, Xie JS, Cattaneo S, Durand DJ, Fitton T, Kuang JQ, Stewart G, Lehrke S, Baumgartner WW, Martin BJ, Heldman AW, Hare JM. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A. 2005;102:11474-11479.
39. Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM, Pittenger MF, Martin BJ. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg. 2002;73:1919-1925.
40. Chen SL, Fang WW, Ye F, Liu YH, Qian J, Shan SJ, Zhang JJ, Chunhua RZ, Liao LM, Lin S, Sun JP. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction. Am J Cardiol. 2004;94:92-95.
41. Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F, Salio M, Battaglia M, Latronico MV, Coletta M, Vivarelli E, Frati L, Cossu G, Giacomello A. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res. 2004;95:911-921.
42. Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y, Pocius J, Michael LH, Behringer RR, Garry DJ, Entman ML, Schneider MD. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A. 2003;100:12313-12318.
43. Valiunas V, Doronin S, Valiuniene L, Potapova I, Zuckerman J, Walcott B, Robinson RB, Rosen MR, Brink PR, Cohen IS. Human mesenchymal stem cells make cardiac connexins and form functional gap junctions. J Physiol. 2004;555:617-626.
44. Valiunas V, Polosina YY, Miller H, Potapova IA, Valiuniene L, Doronin S, Mathias RT, Robinson RB, Rosen MR, Cohen IS, Brink PR. Connexin-specific cell-to-cell transfer of short interfering RNA by gap junctions J Physiol. 2005;568:459-468.
45. Perin EC, Silva GV. Stem cell therapy for cardiac diseases. Curr Opin Hematol. 2004;11:399-403.
46. Vulliet PR, Greeley M, Halloran SM, MacDonald KA, Kittleson MD. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet. 2004;363:783-784.
47. Mudur GS. Big wonder cells mess. The Telegraph: Calcutta. November 20, 2005.
48. Stem cell information: the official NIH resource for stem cell research. Modified February 10, 2006. Available at: http://stemcells.nih.gov/index.asp. Accessed October 14, 2006.
49. Federal Food, Drug, and Cosmetic Act, Section 1, chapter ii, definitions.
50. Food and Drug Administration Progress and Priorities 2004: Protecting and Advancing America's Health. Washington, DC: US Department of Health and Human Services, FDA; September 2004.
51. Kennedy D. FDA centennial. Science. 2006;312:19.
52. Green MD, Schultz WB. Tort law deference to FDA regulation of medical devices. Georgetown Law J. 2000;88:2119-2145.
53. Harris G. Report details FDA rejection of the next day pill. New York Times. November 15, 2005.
54. Harris G. US rules morning after pill can't be sold over the counter. New York Times. May 18, 2006.
55. Warner JH. Towards a new regulatory framework for human cells and tissue: FDA and the new paradigm for tissue regulation. Dallas, Tex. February 2005. Available at: http://www.fda.gov/cber/summaries/tisreg020105jh.pdf. Accessed October 9, 2006.
56. Bauer SR. Potential Use of Tissue, Gene and Cell Therapy Products: Repair, Replace, Restore, Regenerate. Rockville, Md: Office of Cellular, Tissue, and Gene Therapy; October 2002.
57. Wells MA. Scope of regulatory approach for cellular therapies under 21 CFR part 1271. Paper presented at: ISCT/cGTP Workshop; May 2005; Vancouver, Canada.
58. Commission Directive 2006/17/EC of 8 February 3, 2006, implementing Directive 2004/23/EC of the European Parliament and the Council as regards certain technical requirements for the donation, procurement and testing of human tissue and cells. Official Journal of the European Union. February 9, 2006;L38:40.
59. Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissue cells. Official Journal of the European Union April 7, 2004;L102:48-58.
60. Vogel G. International standards proposed for stem cell work. Science. 2006;313:26.
61. Specter M. Political science: the Bush administration's war on the laboratory. The New Yorker. March 13, 2006:58-69.